期刊文献+

miR-145、miR-21、miR-10b在乳腺癌中的表达及意义 被引量:9

miR-145, miR-21, miR-10b expression and significance in breast cancer
原文传递
导出
摘要 目的 探讨miR-145、miR-21、miR-10b在乳腺癌中的表达及意义,为进一步提高乳腺癌诊治水平提供理论实践基础.方法 采用Real-time PCR法检测35例乳腺癌组织及其癌旁正常乳腺组织中miR-145、miR-21、miR-10b的表达,分析其与乳腺癌临床病理特征的关系;同时用免疫组化检查乳腺癌中ER、PR的表达;荧光原位杂交检测HER-2、TOP 2A的表达.结果 miR-145在乳腺癌组织中的表达低于癌旁正常组织,仅为正常组织的0.78倍,但差异无统计学意义,在肿块大小、淋巴结转移、ER阳性、HER-2阳性、TOP 2A阳性患者中低表达(P<0.05),与年龄、月经、PR表达无关.miR-21、miR-10b在乳腺癌组织中的表达明显高于癌旁组织,分别是正常组织的8.58倍、1.70倍(P<0.05).miR-21在年老、绝经、淋巴结转移、HER-2阳性患者中高表达(P<0.05),与肿块大小、ER、PR、及TOP 2A的表达程度无关.miR-10b在肿块大小、淋巴结转移、TOP 2A阳性中高表达(P<0.05),而与患者年龄、月经、ER、PR、HER-2等无关.结论 miR-145、miR-21、miR-10b在乳腺癌发展、侵袭的过程中可能发挥重要作用. Objective To investigate the significance of miR-145,and miR-21,the role of miR-10b in breast cancer,providing theoretical and practical foundation for further improving the diagnosis and treatment of breast cancer.Methods Real-time RT-PCR detected 35 cases of breast cancer and adjacent normal breast tissue miR-145,miR-21,miR-10b expression,and analysis of their relationship with clinico-pathological features of breast cancer; the expression was examined by immunohistochemistry in breast cancer ER,PR expression; fluorescencein situ hybridization in detection of HER-2,TOP 2A.Results Expression of miR-145 in breast cancer tissues was lower than in adjacent normal tissue,only 0.78 of normal tissue,but without statistical significance.miR-145 in large lumps,lymph node metastasis,ER-positive,HER-2 positive,TOP 2A-positive patients with low expression (P < 0.05),with age,menstruation,PR expression is independent.Expression of miR-21,miR-10b in breast cancer tissues was significantly higher than that in adjacent normal tissue,which are 8.58,1.70 times the normal tissues (P <0.05).MiR-21 in old age,menopause,lymph node metastasis,HER-2 positive patients with high expression (P <0.05),regardless of tumor size,ER,PR,and the degree of expression of TOP 2A; miR-10b in large lumps,lymph node metastasis,TOP 2A high positive expression (P < 0.05),while with age,menstruation,ER,PR,HER-2 independent.MiR-10b in large lumps,lymph node metastasis,the positive expression TOP 2A high expression (P < 0.05),and with age,unrelated to menstruation,ER,PR,HER-2 expression.Conclusions miR-145,miR-21 and miR-10b in breast cancer development,invasion process may play an important role.
出处 《国际外科学杂志》 2014年第6期405-409,F0003,共6页 International Journal of Surgery
基金 西安市社会发展引导计划[No.SF1203(4)] 陕西省国际合作重点项目(No.2013KW-32-01) 西安交通大学第二附属医院人才培养专项[No.RC(GG)201203]
关键词 乳腺肿瘤 微小RNAS TOP 2A 基因 Breast neoplasms MicroRNAs TOP 2A Genes
  • 相关文献

参考文献13

  • 1李志华,罗永辉.miRNA与乳腺癌转移[J].国际外科学杂志,2010,37(1):46-48. 被引量:8
  • 2Sachdeva M,Zhu S,Wu F,et al.p53 represses c-Myc through induction of the tumor suppressor miR-145[J].Proc Natl Acad Sci U S A,2009,106(9):3207-3212.
  • 3Ma L,Reinhardt F,Pan E,et al.Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model[J].Nat Biotechnol,2010,28(4):341-347.
  • 4Ozgün A,Karagoz B,Bilgi O,et al.MicroRNA-21 as an indicator of aggressive phenotype in breast cancer[J].Onkologie,2013,36(3):115-118.
  • 5Bouchalová K,Trojanec R,Kolár Z,et al.Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer[J].Neoplasma,2006,53(5):393-401.
  • 6李佳,房林.microRNAs在乳腺癌及乳腺癌干细胞中的研究进展[J].国际外科学杂志,2011,38(9):632-635. 被引量:2
  • 7Ibrahim SA,Yip GW,Stock C,et al.Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase-and E-cadherin-dependent mechanism[J].Int J Cancer,2012,131(6):E884-896.
  • 8Ng EK,Li R,Shin VY,et al.Circulating microRNAs as specific biomarkers for breast cancer detection[J].PLoS One,2013,8(1):e53141.
  • 9Chen W,Cai F,Zhang B,et al.The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer:potential biomarkers[J].Tumour Biol,2013,34 (1):455-462.
  • 10Chan M,Liaw CS,Ji SM,et al.Identification of circulating microRNA signatures for breast cancer detection[J].Clin Cancer Res,2013,19 (16):4477-4487.

二级参考文献29

  • 1侯晓玮,王雅杰,王梅,朱玉兆,李永梅.同源异型盒基因HOXD10在乳腺癌组织中的表达及其临床病理意义[J].中国癌症杂志,2007,17(6):448-452. 被引量:5
  • 2Shimono Y, Zabala M, Cho RW, et al. Downregulation of miR- NA-200c links breast cancer stem cells with normal stem cells[J]. Cell, 2009, 138(3) : 592-603.
  • 3Yu FY, Yao HR, Zhu PC. let-7 regulates self renewal and tumori- genicity of breast cancer cells[J]. Cell, 2007, 131(6) : 1109- 1123.
  • 4Yu F, Deng H, Yao H, et al. Mir-30 reduction maintains self-reuewal and inhibits apoptosis in breast tumor-initiating cells [ J ]. Oncogene, 2010, 29 (29) : 4194-4204.
  • 5Mehzer PS. Cancer genomics: small RNAs with big impacts [ J ]. Nature, 2005, 435(7043): 745-746.
  • 6江立玉 孔晓丽 孙靖中.肿瘤干细胞对恶性肿瘤诊治的意义.国际外科学杂志,2008,35(5):346-349.
  • 7Iorio M V, Ferracin M, Liu CG, et al. microRNA gene expression deregulation in human breast cancer [ J]. Cancer Res, 2005, 65 (16) : 7065~7070.
  • 8Yah LX, Huang XF, Shao Q, et al. microRNA miR-21 overexpression in human breast cancer is associated with advanced clini- cal stage, lymph node metastasis and patient poor prognosis [ J ]. RNA, 2008, 14(11) : 2348-2360.
  • 9Lodygin D, Tarasov V, Epanchintsev A, et al. Inactivation of miR- 34a by aberrant CpG methylation in multiple types of cancer [ J ]. Cell Cycle, 2008, 7(16) : 2591-2600.
  • 10Calin GA, Croce CM. microRNA signatures in human cancers[J].Nat Rev Cancer, 2006, 6(11) : 857-866.

共引文献8

同被引文献64

  • 1GIBBINGS D,MOSTOWY S,JAY F,et al. Corrigendum: Selective autophagy degrades DICER and AGO2 and regulates miRNA activity [ J ]. Nat Cell Biol, 2015,17 (8): 1 088--1 091.
  • 2PRODROMAKI E,KORPETINOU A,GIANNOPOULOU E,et al. Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas [J]. Cell Oncol (Dordr) ,2015,38(4):307--317.
  • 3MERRITF W M, LIN Y G, HAN L Y, et al. Dicer, Drosha, and outcomes in patients with ovarian cancer[J]. N Engl J Med,2008,359(25):2641--2650.
  • 4AHMAD A, GINNEBAUGH K R,YIN S,et al. Functional role of miR-lOb in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4 [J]. BMC Cancer,2015, 24(15):540--545.
  • 5HUANG J,SUN C,WANG S,et al. micoRNA miR-lOb inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells [J]. Mol Biosyst, 2015, 11 (7):2 051 --2 059.
  • 6MEDIMEGH I, OMRANE I, PRIVAT M, et al. MicroRNAs exp'ession in triple negative vs non tiple negative breast cancer it Tunisia'. interaction with clinical outcome [J ]. PLoS One, 2014,9( 11 ):el 11 877.
  • 7EISSA S, MATBOLI M, SHEHATA H H, et al.MicroRNA 10b and minichromosome maintenance complex component 5 gene as prognostic biomarkers in breast cancer[J]. Tu- rnout Biol,2Ol5,36(6):4 487--4 494.
  • 8AVERY-KIEJDA K A,BRAYE S G,FORBES J F,et al. The expression of Dicer and rosha in matched normal tis- sues, tumours and lymph node metastases in triple negative breast cancer[ J ]. BMC Cancer, 2014, 11 ( 14):253--257.
  • 9POURSADEGH ZONOUZI A A,NEJATIZADEH A, RAHMATI-YAMCHI M F,et al. Dysregulated expression of Dicer in invasive ductal breast carcinoma[J]. Med On- col, 2015,32(7 ):203--213.
  • 10Farazi TA,Horlings HM,Ten Hoeve JJ,et al.Micro RNA sequence and expression analysis in breast tumors by deep sequencing[J].Cancer Res,2011,71(13):4443-4453.

引证文献9

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部